Codice QR

Cabazitaxel multiple rechallenges in metastatic castration‐resistant prostate cancer

Abstract Introduction Cabazitaxel multiple rechallenges may be a treatment option in heavily pretreated patients with metastatic castration‐resistant prostate cancer (mCRPC) who had a good initial response to cabazitaxel and who are still fit to receive it. Our objective was to assess the efficacy a...

Descrizione completa

Salvato in:
Autori principali: Cedric Pobel, Edouard Auclin, Diego Teyssonneau, Brigitte Laguerre, Mathilde Cancel, Elouen Boughalem, Johanna Noel, Pierre Emmanuel Brachet, Denis Maillet, Philippe Barthelemy, Carole Helissey, Constance Thibault, Stéphane Oudard
Natura: Artigo
Lingua:Inglês
Pubblicazione: Wiley 2021-09-01
Serie:Cancer Medicine
Soggetti:
prostate cancer
chemotherapy
metastasis
cancer management
urological oncology
Accesso online:https://doi.org/10.1002/cam4.4172
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi